iSpecimen Inc. Files 8-K Amendment on Officer/Director Changes

Ticker: ISPC · Form: 8-K/A · Filed: 2025-02-28T00:00:00.000Z

Sentiment: neutral

Topics: officer-changes, director-changes, amendment

TL;DR

iSpecimen filed an 8-K/A amendment covering director/officer changes and compensation. Check for leadership shifts.

AI Summary

iSpecimen Inc. filed an amendment (No. 1) to its Form 8-K on February 28, 2025, reporting events that occurred on February 19, 2025. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. It also includes financial statements and exhibits.

Why It Matters

This amendment provides updated information regarding the company's leadership and executive compensation, which can be crucial for investors assessing corporate governance and potential strategic shifts.

Risk Assessment

Risk Level: medium — Amendments to 8-Ks concerning director and officer changes can indicate internal shifts that may impact company strategy or stability.

Key Players & Entities

FAQ

What specific events are detailed in the 8-K/A amendment filed by iSpecimen Inc.?

The amendment details the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.

When was the earliest event reported in this filing?

The earliest event reported was on February 19, 2025.

What is the filing date of this amendment?

The filing date of this amendment is February 28, 2025.

What is the principal executive office address for iSpecimen Inc.?

The principal executive offices are located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.

What is the SEC file number for iSpecimen Inc.?

The SEC file number for iSpecimen Inc. is 001-40501.

From the Filing

0001213900-25-018804.txt : 20250228 0001213900-25-018804.hdr.sgml : 20250228 20250228163023 ACCESSION NUMBER: 0001213900-25-018804 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250219 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250228 DATE AS OF CHANGE: 20250228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 25690892 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K/A 1 ea0232619-8ka1_ispecimen.htm AMENDMENT NO. 1 TO FORM 8-K true 0001558569 0001558569 2025-02-19 2025-02-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K/A (Amendment No. 1)   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): February 19, 2025   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road, Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Explanatory Note   This Amendment No. 1 to the Current Report on Form 8-K amends the Form 8-K originally filed with the Securities and Exchange Commission on February 24, 2025 (the “Original Form 8-K”). At the time of the Original Form 8-K, iSpecimen Inc. (the “Company”) had not yet determined the compensation arrangements for Ms. Katharyn Field, who was appointed as President of the

View on Read The Filing